AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in the U.S. Pharmaceutical Investing
Gain Therapeutics Reports Financial Results for Second Quarter 2025 and Provides Corporate Update Biotech Investing
Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates Biotech Investing
PADCEV Plus KEYTRUDA Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery Pharmaceutical Investing
Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress Biotech Investing
Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 45th Annual Growth Conference Biotech Investing
Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer Pharmaceutical Investing
